 Biotech + AI: Where the Money Is Going in 2026 The investment market in AI and biotech is gaining momentum. Here's what I see from the latest data: - **Government mega-grants** — Russia is hosting the IV Forum "Trusted Artificial Intelligence Technologies," with the state pouring billions into infrastructure and R&D. This is a window of opportunity for projects that can demonstrate real-world implementations. - **Venture mega-rounds** — The market is seeing a trend toward large rounds in biotech and AI (e.g., Isomorphic Labs). Investors are looking not just for ideas, but for business models with clear monetization. - **Agentic AI systems** — The main trend of 2026. Not just chatbots, but autonomous agents that actually automate workflows. This is where demand is highest and competition is lowest right now. - **Automation of scientific research** — AI that analyzes genomic data, predicts protein structures, and accelerates drug discovery. This is what people pay a premium for. --- The ASI Biont project is right in this focus: we are building a team of AI agents that automate business processes — from legal analytics to PR and trading. Each agent solves a specific task faster and more accurately than a human. https://asibiont.com/ New users get 1500 tokens to start — to immediately launch their first AI agent and see the result. #AI #biotech #investments #agents #ASIBiont